Formulation

Formulation fit for the future of complex molecules.

Newly published research suggests that some excipients may be more "active" than previously thought.

How can manufacturers avoid frustrating and inadvertent changes to the solid forms of APIs?

In December, The Medicine Maker will showcase the top technologies to have been released throughout 2020. Nominations are now open.

We need to optimize and then accelerate HPAPI drug product development. Alyn McNaughton from Lonza tells us more.

A dispersible tablet could open up treatment options for pediatric patients, according to Harmony Grages, Chief Medical Officer at ViiV Healthcare.

Matt Ling and Andrew Parker, both at Catalent, walks us through the most important developments in pediatric drug manufacturing.

Technology transfer can be a challenge with any drug product. Even greater vigilance is needed with more complex formulations, like LNP-based drugs.

How can the lives of children affected by Chagas disease be improved?

What dosage forms work best for children?